|
|||||
|
|
Elimination of dormant,autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition |
|
| Authors: | Alicia M. Blessing MD PhD Janice M. Santiago-O'Farrill MD PhD Weiqun Mao BS MD Lan Pang BS MD Jing Ning MD PhD Daewoo Pak MD PhD Lakshmi Reddy Bollu MD PhD Philip Rask BS MD LaKesla Iles BS MD Hailing Yang PhD MD Samantha Tran BS MD Ezzeddine Elmir BS MD Geoffrey Bartholomeusz MD PhD Robert Langley MD PhD Zhen Lu MD Robert C. Bast Jr MD |
| Affiliation: | 1. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA;2. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA |
| Abstract: | |
| Keywords: | anaplastic lymphoma kinase (ALK) autophagy crizotinib dormancy GTP-binding protein Di-Ras3 (DIRAS3) ovarian cancer |